186 related articles for article (PubMed ID: 31202735)
1. Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis.
Alwhaibi A; Verma A; Artham S; Adil MS; Somanath PR
Biochem Pharmacol; 2019 Oct; 168():1-13. PubMed ID: 31202735
[TBL] [Abstract][Full Text] [Related]
2. Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial-mesenchymal transition in prostate cancer.
Yang M; Liu H; Qiu GP; Gao F
Med Oncol; 2021 Nov; 39(1):8. PubMed ID: 34761338
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR
Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980
[TBL] [Abstract][Full Text] [Related]
4. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
6. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Akt1 loss promotes prostate cancer metastasis via β-catenin-regulated tight-junction protein turnover.
Gao F; Alwhaibi A; Artham S; Verma A; Somanath PR
Br J Cancer; 2018 May; 118(11):1464-1475. PubMed ID: 29755115
[TBL] [Abstract][Full Text] [Related]
9. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
[TBL] [Abstract][Full Text] [Related]
10. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
12. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.
Luo W; Tan P; Rodriguez M; He L; Tan K; Zeng L; Siwko S; Liu M
J Biol Chem; 2017 Sep; 292(37):15525-15537. PubMed ID: 28768769
[TBL] [Abstract][Full Text] [Related]
13. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
15. Rubus idaeus L Inhibits Invasion Potential of Human A549 Lung Cancer Cells by Suppression Epithelial-to-Mesenchymal Transition and Akt Pathway In Vitro and Reduces Tumor Growth In Vivo.
Chu SC; Hsieh YS; Hsu LS; Chen KS; Chiang CC; Chen PN
Integr Cancer Ther; 2014 May; 13(3):259-73. PubMed ID: 24335666
[TBL] [Abstract][Full Text] [Related]
16. AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis.
Chou CC; Lee KH; Lai IL; Wang D; Mo X; Kulp SK; Shapiro CL; Chen CS
Cancer Res; 2014 Sep; 74(17):4783-95. PubMed ID: 24994714
[TBL] [Abstract][Full Text] [Related]
17. LOX-1 activation by oxLDL triggers an epithelial mesenchymal transition and promotes tumorigenic potential in prostate cancer cells.
González-Chavarría I; Fernandez E; Gutierrez N; González-Horta EE; Sandoval F; Cifuentes P; Castillo C; Cerro R; Sanchez O; Toledo JR
Cancer Lett; 2018 Feb; 414():34-43. PubMed ID: 29107109
[TBL] [Abstract][Full Text] [Related]
18. Endothelial stromelysin1 regulation by the forkhead box-O transcription factors is crucial in the exudative phase of acute lung injury.
Artham S; Gao F; Verma A; Alwhaibi A; Sabbineni H; Hafez S; Ergul A; Somanath PR
Pharmacol Res; 2019 Mar; 141():249-263. PubMed ID: 30611853
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 Promotes Prostate Cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling Pathway.
Lv DJ; Song XL; Huang B; Yu YZ; Shu FP; Wang C; Chen H; Zhang HB; Zhao SC
Theranostics; 2019; 9(18):5166-5182. PubMed ID: 31410208
[No Abstract] [Full Text] [Related]
20. Regulation of Let-7a-5p and miR-199a-5p Expression by Akt1 Modulates Prostate Cancer Epithelial-to-Mesenchymal Transition via the Transforming Growth Factor-β Pathway.
Alwhaibi A; Parvathagiri V; Verma A; Artham S; Adil MS; Somanath PR
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
